Our research revealed that NDE1 is strongly linked to tumour mutation burden (TMB), microsatellite instability (MSI), tumour purity and homologous recombination deficit (HRD) in a range of tumours, in addition to immune checkpoint genes in the majority of tumours. This evidence concerns the gene NDE1 and neoplasm.